Cargando…

1462. The protective effect of pneumococcal vaccination on cardiovascular disease in adults: A systematic review and meta-analysis

BACKGROUND: Epidemiological studies suggest a link between pneumococcal infection and an adverse cardiovascular outcome such as myocardial infarction. Therefore, studies have evaluated the protective effect of the 23-valent polysaccharide pneumococcal vaccination (PPV23), but results have varied. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marra, Fawziah, Zhang, Angel, Gillman, Emma, Bessai, Katherine, Parhar, Kamalpreet, Vadlamudi, Nirma Khatri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776373/ http://dx.doi.org/10.1093/ofid/ofaa439.1643

Ejemplares similares

2302. A Meta-Analysis of Risk Factors for Herpes Zoster Infection
por: Parhar, Kamalpreet K, et al.
Publicado: (2019)

Efficacy and Safety of the Pneumococcal Conjugate-13 Valent Vaccine in Adults
por: Marra, Fawziah, et al.
Publicado: (2019)

Risk Factors for Herpes Zoster Infection: A Meta-Analysis
por: Marra, Fawziah, et al.
Publicado: (2020)

1397. Long term impact of the 13-valent pneumococcal conjugate vaccine use in infant immunization program on all-cause pneumonia hospitalizations in British Columbia, Canada: a time series analysis
por: Vadlamudi, Nirma Khatri, et al.
Publicado: (2020)

2701. The Impact of Infant 13-valent Conjugate Pneumococcal Vaccination Program on Invasive Pneumococcal Disease in Children in British Columbia, Canada
por: Vadlamudi, Nirma K, et al.
Publicado: (2019)

2706. Indirect Effects of Infant 13-valent Conjugate Pneumococcal Vaccination Program on Invasive Pneumococcal Disease in Adults in British Columbia, Canada
por: Vadlamudi, Nirma K, et al.
Publicado: (2019)

2705. Serotype Replacement Following Childhood Pneumococcal Conjugate Vaccination Programs in British Columbia, Canada
por: Vadlamudi, Nirma K, et al.
Publicado: (2019)

Incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate pneumococcal vaccine in British Columbia: A retrospective cohort study
por: Vadlamudi, Nirma Khatri, et al.
Publicado: (2020)

2596. Title: The Dynamics Of Invasive Pneumococcal Disease (IPD) due to Streptococcus pneumoniae and Impact Of Pneumococcal Conjugate Vaccines (PCVs) In Canada From 2000-2019
por: Ramos, Bernice N, et al.
Publicado: (2023)

Abstracts from USCAP 2019: Infectious Disease Pathology (1435-1462)
Publicado: (2019)

Abstracts from USCAP 2019: Infectious Disease Pathology (1435-1462)
Publicado: (2019)

1462. Derivation of a Prediction Model for Risk of Drug-Resistant Urinary Tract Infection
por: Ali, Sabeen, et al.
Publicado: (2019)

Immunogenicity and Safety of the COVID-19 Vaccines Compared With Control in Healthy Adults: A Qualitative and Systematic Review
por: Lau, Oscar, et al.
Publicado: (2022)

1462. Analysis of Clindamycin and Vancomycin Use and Reported Beta Lactam Allergy in Procedural Antimicrobial Prophylaxis
por: Veach, Lisa A, et al.
Publicado: (2023)

P1462: NEUROCOGNITIVE FUNCTION AND PSYCHOLOGICAL ASSESSMENT IN TRANSFUSION-DEPENDENT BETA-THALASSEMIA PATIENTS: RELATION TO BRAIN IRON CONTENT
por: Adly, Amira, et al.
Publicado: (2023)

13. The Efficacy and Effectiveness of Pneumococcal Vaccines against Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis
por: Childs, Lana, et al.
Publicado: (2021)

180. Impact of Pneumococcal Conjugative Vaccine on Antibiotic Resistant Invasive Pneumococcal Disease in the United States
por: Bajema, Kristina, et al.
Publicado: (2020)

1373. Vaccine Effectiveness and Pneumococcal Serotypes in Pediatric Otitis Media in the Era of Routine 13-valent Pneumococcal Vaccination in the United States
por: Hulten, Kristina G, et al.
Publicado: (2020)

Structural characterization of CA1462, the Candida albicans thiamine pyrophosphokinase
por: Santini, Sébastien, et al.
Publicado: (2008)

295. Is Herd Immunity from Pneumococcal Conjugate Vaccines Changing the Clinical Features of Invasive Pneumococcal Disease in Adults?
por: McGeer, Allison, et al.
Publicado: (2020)

1474. Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Non-bacteremic Pneumococcal Pneumonia (NBPP) among Adults in the United States, 2013-2017
por: Gierke, Ryan, et al.
Publicado: (2020)

1470. Epidemiology of Invasive Pneumococcal Disease (IPD) Following 18 years of Pneumococcal Conjugate Vaccine (PCV) Use in the United States
por: Pilishvili, Tamara, et al.
Publicado: (2020)

1462. Hospital Admission Patterns in Adult Patients with Community-Acquired Bacterial Pneumonia Who Received Ceftriaxone and a Macrolide by Pneumonia Severity Index Score
por: Lodise, Thomas, et al.
Publicado: (2018)

Strategies to Prevent Early and Late-Onset Group B Streptococcal Infection via Interventions in Pregnancy
por: Delara, Mahin, et al.
Publicado: (2023)

1462 Bronchoalveolar Lavage Lateral-Flow Device Test for Diagnosing Invasive Pulmonary Aspergillosis in ICU patients: a multicenter study
por: Hoenigl, Martin, et al.
Publicado: (2014)

1404. Twenty-year impact of Pneumococcal Conjugate Vaccines (PCV) on the burden of invasive pneumococcal disease in US children less than 5 years of age
por: Lapidot, Rotem, et al.
Publicado: (2020)

1242. Safety and Immunogenicity of Novel 24-Valent Pneumococcal Vaccine in Healthy Adults
por: Chichili, Gurunadh, et al.
Publicado: (2020)

06. United States Healthcare Provider Preferences for Adult Pneumococcal Vaccine Recommendations
por: Vietri, Jeffrey, et al.
Publicado: (2021)

15. Evaluation of Retained Immunity for Tetanus-Diphtheria and Pneumococcal Vaccines in Recipients of Cellular Therapies
por: Angelidakis, Georgios, et al.
Publicado: (2021)

214. Antibiotic Use for Common Infections in British Columbia: A Review of Outpatient Prescribing from 2000 - 2018
por: Saatchi, Ariana, et al.
Publicado: (2020)

176. Selected Impact of the 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Invasive Pneumococcal Disease (IPD) at Eight Children’s Hospitals in the United States. 2014–2019
por: Kaplan, Sheldon L, et al.
Publicado: (2020)

1480. Incidence of Non-Invasive Pneumococcal Pneumonia in Children in the United States before and after Introduction Pneumococcal Conjugate Vaccines (PCV7 and PCV13) during 1998-2018
por: Hu, Tianyan, et al.
Publicado: (2020)

35. Pneumococcal Vaccination in High-Risk Adults: An Initial Analysis Incorporating Social Determinants of Health
por: Gatwood, Justin, et al.
Publicado: (2020)

30. Impact of Pharmacist Assertiveness Training in Recommending Pneumococcal Vaccination among High-Risk Adults
por: Gatwood, Justin, et al.
Publicado: (2020)

P1462: POPULATION-BASED REAL WORLD RESULTS OF CD19-DIRECTED CAR T-CELL THERAPY FOR PATIENTS WITH RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA: A DUTCH CAR T-CELL TUMORBOARD EXPERIENCE
por: Spanjaart, A. M., et al.
Publicado: (2022)

221. Comparison of dental antibiotic prescribing between Australia, England, the United States and British Columbia in 2017
por: Teoh, Leanne, et al.
Publicado: (2020)

1384. Conceptual Economic Model Methodology for Infant Pneumococcal Conjugate Vaccine Program and its Impact on Antimicrobial Resistance
por: Farkouh, Raymond, et al.
Publicado: (2020)

1394. Impact of 7-Valent and 13-Valent Pneumococcal Conjugate Vaccines in the United States: A Systematic Literature Review
por: Kistler, Kristin, et al.
Publicado: (2020)

1236. Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Healthy Infants in the United States
por: Senders, Shelly, et al.
Publicado: (2020)

1240. Persistence of Circulating Antibody Through 12 Months Following Vaccination With a 20-Valent Pneumococcal Conjugate Vaccine in Adults 60–64 Years of Age
por: Hurley, Donald, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qdl0k8ie6m8lmdg0eak4588q9b